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Introduction
According to the Polish Carcinoma Registry, gastric
cancer is the second most common malignancy among
men and the eighth in women [1]. The 5-year survival
rate is only 18%. Before Helicobacter pylori was dis-
covered, high incidence of gastric carcinoma had been
associated with such risk factors as diet and lifestyle
(ethnicity, nitrates and nitrites-rich diet, smoking and
alcohol abuse). Carcinogenesis is a multistage process,
which in gastric cancer begins with chronic inflamma-
tion of the gastric mucosa that develops into chronic
atrophic inflammation (intestinal metaplasia) and
eventually leads to dysplasia. A relationship has been
found between Helicobacter pylori infection and
chronic atrophic inflammation of the gastric mucosa.
Thus, H. pylori may play a role in gastric carcinoma
progression [2]. This hypothesis has been confirmed
by a number of studies in the past several dozen years
and approximately 35-60% of gastric cancers have
been reported to be associated with H. pylori infection
[3]. In the year 1994, World Health Organization
(WHO) considered H. pylori to be class 1 carcinogen
[4]. Helicobacter pylori is a gram-negative bacterium,
0.5 do 3 μm in size, known to colonize the gastric
mucosa. It is elongated, spiral and has 3-7 long flagel-
la at one end that allow movement. It has been esti-
mated that this bacterium occurs in two-thirds of the
world population. H. pylori is responsible for 80% of
cases of gastric ulcer and 90% of duodenal ulcer. It
shows resistance to gastric acid, and produces large
amounts of urease, i.e. the enzyme catalysing degrada-
tion of urea to ammonium and carbon dioxide. Ammo-
nium causes neutralization of hydrochloric acid (pres-
ent in gastric juice) in a direct vicinity of the bacteria,
thus enabling their survival. The harmful effect of H.
pylori involves the release of toxins that initially cause
mucosa inflammation; however, the process initiating
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tumour formation and progression by H. pylori is still
not fully elucidated [5,6]. There is a search for evi-
dence whether H. pylori can affect the expression of
the respective proteins also associated with the devel-
opment of gastric carcinoma. EGF is suspected to play
the major role in this mechanism  [7]. 
The epidermal growth factor (EGF) is a single
polypeptide built of 53 amino acids and playing an
essential role in intercellular interactions. Cooperation
between the epidermal growth factor of one cell and
the receptor (EGFR) on the adjacent cell leads to some
biological effects, including migration, growth or mor-
phological changes in the cell. EGF stimulates the
growth or exerts a trophic effect in many tissues, and
plays an important role in proliferation, differentiation
and maturation of embryonic cells. However, EGF and
EGFR, apart from the key role they play in physiolog-
ical development, also take part in neoplastic transfor-
mation. Increased expressions of EGF and EGFR have
been observed in various malignancies, including gas-
tric carcinoma [8]. Substantial evidence has been also
provided for neoplastic oncogene HER-2/neu (cerbB-
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Fig. 1. Expression of EGFR in gastric
cancer (original magnification ×40).
Fig. 3. Expression of c-erbB-2 in gastric
cancer (original magnification ×40).
2), which encodes transmembrane glycoprotein close-
ly related to the epidermal growth factor receptor,
whose overexpression has also been observed in gas-
tric carcinoma [9].
The current study objective was to assess the
expressions of the epidermal growth factor (EGF), the
epidermal growth factor receptor (EGFR) and c-erbB-
2 (HER-2/neu) in patients with gastric carcinoma in
correlation with Helicobacter pylori infection.
Materials and methods
Material. Fifty-five patients treated for gastric carcinoma in II
Department of General Surgery and Gastroenterology, Medical
University of Bia³ystok in the years 1991-2003 were recruited to
the study.
Endoscopic specimens were stained with Giemza solution for
the presence of Helicobacter pylori. The inflammation and the
degree of Helicobacter pylori infection were classified according
to the Sydney system [10]. The degree of infection was assessed
using the scale: 0 -lack of infection, 1- low, 2 – moderate, 3 – high. 
Immunohistochemistry. Immunohistochemical investigation was
performed according to the following protocol. Fifty-five tumour
specimens and twenty-eight local lymph node samples, formalin-
fixed and paraffin-embedded, were cut on a microtom into 5µm
sections. The sections were deparaffinized in xylenes and hydrated
in alcohols. In order to expose the antigen, the sections were heat-
ed in a microwave for 15 min in citrate buffer (pH 6.0). To block
endogenous peroxidase, incubation was performed with 0.5%
hydrogen peroxide in methanol. Next, they were incubated with
monoclonal antibodies against c-erbB-2 (Novocastra, NCL-c-
erbB-2-316) overnight, with EGF (EGF-Sigma, clone EGF-10,
Sigma-Aldrich, Poland) for 60 min at room temperature and with
EGFR (EGFR, clone H11, Dako, Poland). The reaction was con-
ducted using the ABC technique with a Novostatin Super ABC
Universal Kit (Novocastra Laboratories Ltd.) Colour reaction for
peroxidase was performed with chromogen DAB (DAKO S3000,
DAKO, Poland) (Fig. 1,2,3).
Evaluation of samples. Protein expression was assessed using a
semiquantitative method and the reaction was labelled as: 
• (-) – lack of expression of EGF, EGFR, c-erbB-2 or reaction
present in <30% of cells in the main mass of tumour and in
metastatic lymph node 
• (+) – expression of EGF, EGFR, c-erbB-2 in >30% of cells in
the main mass of tumour and in metastatic lymph node
Positive reactions were calculated in at least 500 tumour cells
in each tissue section using a light microscope (×400).
Statistical analysis. Statistical analysis was based on χ2 test and
exact Fisher's test. Correlations between the expressions of the
respective proteins were calculated using Spearman's correlation
coefficient test. The value of p<0.05 was considered statistically
significant.
Results
Of 55 patients with gastric carcinoma, 28 did not have
H pylori infection, 4 patients had low degree infection,
9 moderate and 14 high. No statistically significant
correlation was found between the degree of H. pylori
infection and the expressions of EGF, EGFR and c-
erbB-2 in gastric carcinoma (Table 1). However, sta-
tistically significant correlations were observed
between the respective proteins. The expression of c-
erbB-2 protein in the main mass of tumour correlated
with tumour expressions of EGF and EGFR and with
c-erbB-2 expression in local lymph nodes. The expres-
sion of c-erbB-2 in the lymph node was statistically
significantly correlated with the expressions of EGF
and EGFR both in the main mass of tumour and in the
lymph node. The expression of EGF was also found to
correlate with the expression of EGFR in the main
449Helicobacter pylori and EGF family members in gastric carcinoma
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2009:47(3): 449 (447-451) 
doi: 10.2478/v10042-009-0102-3
Fig. 2. Expression of EGF in gastric
cancer (original magnification ×40).
mass of tumour and the expression of EGF in the
lymph node was observed to correlate with EGFR
expression also in the lymph node (Table 2).
Discussion
Proteins belonging to the family of the epidermal
growth factor (EGF, EGFR, c-erbB-2) are thought to
be involved in neoplastic formation and progression of
gastric cancer. We found correlations between them,
but not between H. pylori infection and EGF expres-
sion, unlike other authors.  Cole et al. [7], who meas-
ured the levels of EGF and EGFR protein by flow
cytometry, found that they doubled in H. pylori infec-
tion. Eradication of the infection reduced the levels of
both proteins. This may be one of the pathomech-
anisms of gastric mucosa hyperproliferation and car-
cinogenesis associated with H. pylori infection, EGF
overexpression and increased density of epidermal
growth factor receptors (EGFR) on cells. Also Wong et
al. [11] measured EGF and EGFR mRNA in gastric
mucosa tissues and saliva using ELISA. Both EGF and
EGFR mRNA were found to increase in the presence
of H. pylori infection in the gastric mucosa. However,
salivary EGF concentration was not found to be relat-
ed to mucosa damage or H. pylori infection.  Success-
ful H. pylori eradication brought EGFR mRNA nor-
malization, whereas with eradication failure the level
remained high.  It can be concluded that H. pylori may
regulate EGFR expression in the gastric mucosa,
which is vital in the treatment of H. pylori infection.
When the infection is untreated, elevated levels of
EGF and EGFR may stimulate cell proliferation and
initiate a neoplatic process. An important study was
conducted by Wallasch et al. [12], who presented a
model in which H. pylori activates the EGFR sig-
nalling pathway, increasing IL-8 production and initi-
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Table 2. Correlations between the degree of H. pylori infection and the level of  c-erbB-2, EGF and EGFR expression in tumour and
lymph node of gastric cancer.
Table 1. Correlation between H. pylori infection degree and
absence or presence of c-erbB-2, EGF and EGFR expression in
gastric cancer.
Correlation is significant at the level of p<0.05. NS – no statistical signifi-
cance 
Correlation is significant at the level of p<0.05. Significant correlation is marked in bold.
ating neoplastic transformation of the gastric mucosa.
Our study, however, did not confirm the hypothesis
that H. pylori may increase the expression of EGF and
EGFR, leading to gastric cancer progression. Broader
investigations are necessary to elucidate the correla-
tions between H. pylori infection and the expression of
epidermal growth factor proteins. We also found no
correlation between H. pylori infection and c-erbB-2
protein expression. The overexpression of c-erbB-2
protein is known to be associated with low differentia-
tion and advancement of cancer and thus with worse
prognosis in patients. Similarly, other researchers
found no relationship between H. pylori and c-erbB-2
protein [13,14]. The current study did not confirm the
hypotheses put forward by other researchers; however,
in our study different methods were used for the eval-
uation of proteins and H. pylori infection.
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